Firefly Bio Debuts With $94 Million Series A Financing : vimarsana.com

-- Transformational degrader antibody conjugate company backed by leading syndicate including founding investor Versant Ventures, MPM BioImpact, Decheng Capital and Eli Lilly & Company --SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Firefly Bio emerged from stealth mode with a $94 million Series A financing co-led b...

Related Keywords

Canada , Todd Foley , Bernhard Geierstanger , Scott Hirsch , Carolyn Bertozzi , Jerel Davis , John Flygare , Eli Lilly Company , Genentech , Basel Technology Park , Leadership Team , Linkedin , Instagram , Facebook , Novartis , Versant Ventures , Decheng Capital , Eli Lilly , Firefly Bio , Ridgeline Discovery Engine , Basel Technology , Managing Director , Chief Operating Officer , South San Francisco ,